Casilda Llácer

983 total citations · 1 hit paper
11 papers, 477 citations indexed

About

Casilda Llácer is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Casilda Llácer has authored 11 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Casilda Llácer's work include Cancer Immunotherapy and Biomarkers (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Breast Cancer Treatment Studies (2 papers). Casilda Llácer is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Breast Cancer Treatment Studies (2 papers). Casilda Llácer collaborates with scholars based in Spain, France and Belgium. Casilda Llácer's co-authors include Martina Álvarez, Ignacio Melero, Pedro Berraondo, Itziar Otano, Virginia Belsúe, Vanesa de Luque, Álvaro Teijeira, Maite Álvarez, Carlos de Andrea and María E. Rodríguez-Ruiz and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Casilda Llácer

11 papers receiving 471 citations

Hit Papers

Prophylactic TNF blockade uncouples efficacy and toxicity... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
    2019 323 citations Elísabeth Pérez-Ruiz, Luna Minute et al. Nature profile →

Peers

Casilda Llácer
Johannes Andel Austria
Margherita Correnti Italy
Marya Chaney United States
Jii Bum Lee South Korea
Jolanta Szelachowska Poland
Jian You China
Petros Fessas United Kingdom
Francesca Sparano Italy
Gerry Gin Wai Kwok China
Simone Punt Netherlands
Johannes Andel Austria
Casilda Llácer
Citations per year, relative to Casilda Llácer Casilda Llácer (= 1×) peers Johannes Andel

Countries citing papers authored by Casilda Llácer

Since Specialization
Citations

This map shows the geographic impact of Casilda Llácer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Casilda Llácer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Casilda Llácer more than expected).

Fields of papers citing papers by Casilda Llácer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Casilda Llácer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Casilda Llácer. The network helps show where Casilda Llácer may publish in the future.

Co-authorship network of co-authors of Casilda Llácer

This figure shows the co-authorship network connecting the top 25 collaborators of Casilda Llácer. A scholar is included among the top collaborators of Casilda Llácer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Casilda Llácer. Casilda Llácer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Auclin, Édouard, Anna Patrikidou, Laura Mezquita, et al.. (2023). Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma. Cancers. 15(4). 1066–1066. 10 indexed citations
2.
Rodríguez, Laura, et al.. (2022). Rechallenge with immune checkpoint inhibitors beyond severe toxicities, an utopia?. Journal of Clinical Oncology. 40(16_suppl). e14601–e14601. 2 indexed citations
3.
Epaillard, Nicolas, Yohann Loriot, Pernelle Lavaud, et al.. (2021). Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study. Frontiers in Oncology. 11. 9 indexed citations
4.
Lorente, David, Casilda Llácer, Rebeca Lozano, et al.. (2021). Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate Cancer. European Urology. 80(5). 641–649. 5 indexed citations
5.
Pérez-Ruiz, Elísabeth, Luna Minute, Itziar Otano, et al.. (2019). Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy. Nature. 569(7756). 428–432. 323 indexed citations breakdown →
6.
Sánchez‐Muñoz, Alfonso, Luís Vicioso, Ángela Santonja, et al.. (2017). Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes. Modern Pathology. 31(2). 299–306. 18 indexed citations
7.
Sánchez‐Muñoz, Alfonso, et al.. (2013). The Role of Immunohistochemistry in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: An Old Tool With an Enduring Prognostic Value. Clinical Breast Cancer. 13(2). 146–152. 22 indexed citations
8.
Ribelles, Nuria, Ángela Santonja, Bella Pajares, Casilda Llácer, & Emilio Alba. (2013). The seed and soil hypothesis revisited: Current state of knowledge of inherited genes on prognosis in breast cancer. Cancer Treatment Reviews. 40(2). 293–299. 43 indexed citations
9.
Sánchez‐Muñoz, Alfonso, et al.. (2012). Targeted therapies in the treatment of germ cell tumors: The need for new approaches against “orphan” tumors. Critical Reviews in Oncology/Hematology. 83(3). 444–451. 5 indexed citations
10.
Jiménez, Begoña, José Trigo, Bella Pajares, et al.. (2012). Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients. Oral Oncology. 49(2). 182–185. 39 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Andel Breakdown of academic impact, for papers by Margherita Correnti Breakdown of academic impact, for papers by Marya Chaney Breakdown of academic impact, for papers by Jii Bum Lee Breakdown of academic impact, for papers by Jolanta Szelachowska Breakdown of academic impact, for papers by Jian You Breakdown of academic impact, for papers by Petros Fessas Breakdown of academic impact, for papers by Francesca Sparano Breakdown of academic impact, for papers by Gerry Gin Wai Kwok Breakdown of academic impact, for papers by Simone Punt
Rankless by CCL
2026